PrescrYbe Tirzepatide Review: Billing Claims and Subscription Terms

PrescrYbe describes semaglutide and tirzepatide treatment through licensed-provider review, including care through OpenLoop Health. Its GLP-1 page advertises no separate membership and says nothing is billed automatically. Its current refund policy nevertheless describes recurring subscriptions and a 72-hour renewal-cancellation deadline.¹²

That contradiction is more important than a generic starting price. The published information supports a real named prescribing pathway, but does not establish one consistent billing arrangement for the particular tirzepatide plan. This review uses public information, without enrolling or completing a consultation.

The named prescribing service

The GLP-1 page expressly describes semaglutide and tirzepatide plans evaluated through OpenLoop, with fulfillment by licensed pharmacy partners when clinically appropriate. It describes provider follow-ups and says live consultation may be required by state law.¹

The platform therefore provides a more specific pathway than a generic wellness page. Still, individual prescribing, formulation and state access depend on an actual review. Ask which clinical practice and clinician handle your case and how to obtain advice if symptoms or a dose change arise after the initial prescription.

The provider's clinical decision should remain separate from selecting a checkout package. A free quiz or a treatment menu is not proof that the requested medicine is suitable or guaranteed.

Category amounts are not a tirzepatide quote

The current page displays starting amounts for microdose injection, medical-weight-loss injection and oral GLP-1 categories. It does not consistently assign a complete named tirzepatide dose, supply and billing schedule to those category figures.¹

Do not use a generic injection amount as a verified tirzepatide price. Request an itemized offer naming the molecule, formulation, weekly milligrams or tablet strength, days supplied, included care and pharmacy charges. A microdose or oral program is a different comparison from a standard weekly injection.

The site says costs are reviewed before treatment is confirmed. Use that opportunity to ask about shipping, supplies, testing, clinical visits and later dose changes. Obtain the exact total due now and the next charge before providing payment authorization.

No automatic billing versus recurring terms

The marketing page says nothing is billed automatically and describes no recurring membership fee disguised as care. The refund policy instead says subscription membership begins after intake and first-month payment, with access to clinicians, medication where appropriate and support.¹²

The policy requires cancellation at least 72 hours before the next billing date. Otherwise the next cycle may be charged and cancellation takes effect later. It allows requests through support or the patient portal where available.²

These could refer to different plans, but the inspected pages do not resolve that distinction. Do not assume that no separate membership means no recurring medication subscription. Ask for the exact selected contract and whether an affirmative approval is required before each refill charge.

Refunds depend on what has happened

The policy describes a full refund for medical disqualification and an early refund if cancellation occurs within the first 72 hours of the term and no subscription services have been received. It says monthly subscriptions generally are not refunded for the cancellation month or prior months.²

For plans charged two or more months at once, the policy describes refunds for months for which medication has not shipped. It also describes handling incorrect or damaged products.² These conditions should not be simplified into an unconditional cancel-anytime refund promise.

Ask when clinical review counts as a service received and when pharmacy fulfillment makes a charge final. Save the selected plan, payment schedule and support's written answer. A future-subscription cancellation and a refund for an already performed consultation are different events.

Dispensing and formulation need confirmation

The reviewed pages describe licensed pharmacy partners without establishing the actual dispenser for a particular order. Obtain the pharmacy's legal identity, contact information and authorization for your state, along with the precise formulation and instructions.¹³

If a compounded product is prescribed, FDA approval should not be inferred from the drug name. FDA states compounded GLP-1 products are not approved and do not undergo its premarket quality, safety and effectiveness review.⁴ Injectable trial results also do not establish equivalence for an oral or microdose formulation.

Our assessment

PrescrYbe has a named clinical pathway and substantive refund provisions. Its unresolved issue is which billing model and complete prescription quote apply to the plan a patient would actually buy. A qualified comparison should preserve that uncertainty instead of advertising either subscription flexibility or a numerical tirzepatide cost that the pages do not establish.

Use other provider reviews, the care-options guide and Zepbound costs to compare the full package after the billing contradiction has been resolved.

To compare why no-membership language does not settle whether medication charges recur, see Metaboost and FeelGood Meds.